Abstract
Abstract
The field of genetics has seen major advances in recent decades, particularly in research, prevention and diagnosis. One of the most recent developments, the genomic editing technique Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, has opened the possibility for genetic therapies through genome modification. The technique marks an improvement on previous procedures but poses some serious ethical conflicts. Bioethics is the discipline geared at finding answers to ethical challenges posed by progress in medicine and biology and examining their repercussions for society. It can also offer a conceptualization of these ethical dilemmas. The aim of this paper is to offer a map of the ethical dilemmas associated with this technique by way of a critical analysis of current literature. The main issues can be grouped in four areas: efficacy and security; the types of cells which can be targeted by the technique (somatic, embryonic and gametes); the goal of the therapy; and accessibility and justice.
Publisher
Springer Science and Business Media LLC
Subject
Management of Technology and Innovation,History and Philosophy of Science,Philosophy,Sociology and Political Science,Social Sciences (miscellaneous)
Reference37 articles.
1. Abel I, Fabre F (2001) Bioética: Orígenes, presente y futuro. Fundación Mapfre IBB, Barcelona
2. Bauman Z (1993) Postmodern ethics. Wiley-Blackwell, Oxford
3. Baumann M (2016) CRISPR/Cas9 genome editing - New and old ethical issues arising from a revolutionary technology. NanoEthics 10:139–159
4. Lorenzo D, Esquerda M (2019) Mapa de conflictos éticos de la técnica de edición genética CRISPR-Cas9. Med Clin 153(9):357–359
5. Bellver V (2016) La revolución de la edición genética mediante CRISPR-Cas9 y los desafíos éticos y regulatorios que comporta. Cuad Bioet 27(2):223–239
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献